首页> 美国卫生研究院文献>Photomedicine and Laser Surgery >Discrimination of Basal Cell Carcinoma and Melanoma from Normal Skin Biopsies in Vitro Through Raman Spectroscopy and Principal Component Analysis
【2h】

Discrimination of Basal Cell Carcinoma and Melanoma from Normal Skin Biopsies in Vitro Through Raman Spectroscopy and Principal Component Analysis

机译:通过拉曼光谱和主成分分析从正常皮肤活检组织中区分基底细胞癌和黑色素瘤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Objective: Raman spectroscopy has been employed to discriminate between malignant (basal cell carcinoma [BCC] and melanoma [MEL]) and normal (N) skin tissues in vitro, aimed at developing a method for cancer diagnosis. >Background data: Raman spectroscopy is an analytical tool that could be used to diagnose skin cancer rapidly and noninvasively. >Methods: Skin biopsy fragments of ∼2 mm2 from excisional surgeries were scanned through a Raman spectrometer (830 nm excitation wavelength, 50 to 200 mW of power, and 20 sec exposure time) coupled to a fiber optic Raman probe. Principal component analysis (PCA) and Euclidean distance were employed to develop a discrimination model to classify samples according to histopathology. In this model, we used a set of 145 spectra from N (30 spectra), BCC (96 spectra), and MEL (19 spectra) skin tissues. >Results: We demonstrated that principal components (PCs) 1 to 4 accounted for 95.4% of all spectral variation. These PCs have been spectrally correlated to the biochemicals present in tissues, such as proteins, lipids, and melanin. The scores of PC2 and PC3 revealed statistically significant differences among N, BCC, and MEL (ANOVA, p<0.05) and were used in the discrimination model. A total of 28 out of 30 spectra were correctly diagnosed as N, 93 out of 96 as BCC, and 13 out of 19 as MEL, with an overall accuracy of 92.4%. >Conclusions: This discrimination model based on PCA and Euclidean distance could differentiate N from malignant (BCC and MEL) with high sensitivity and specificity.
机译:>目的:拉曼光谱已被用于在体外区分恶性(基底细胞癌[BCC]和黑色素瘤[MEL])和正常(N)皮肤组织,旨在开发一种癌症诊断方法。 >背景数据:拉曼光谱法是一种分析工具,可用于快速,无创地诊断皮肤癌。 >方法:通过拉曼光谱仪(830 nm的激发波长,50至200 mW的功率和20 sec的照射)扫描切除手术中约2 mm 2 的皮肤活检碎片。时间)耦合到光纤拉曼探头。采用主成分分析(PCA)和欧氏距离建立区分模型,根据组织病理学对样本进行分类。在此模型中,我们使用了来自N(30个光谱),BCC(96个光谱)和MEL(19个光谱)皮肤组织的145个光谱。 >结果:我们证明了主要成分(PC)1至4占所有光谱变化的95.4%。这些PC已与组织中存在的生物化学物质(例如蛋白质,脂质和黑色素)在光谱上相关。 PC2和PC3的得分显示出N,BCC和MEL之间的统计学差异(ANOVA,p <0.05),并用于判别模型。在30个光谱中,总共28个被正确诊断为N,96个BCC中的93个被正确诊断为MEL,在19个MEL中的19个中,有13个被正确诊断,总准确度为92.4%。 >结论:这种基于PCA和欧氏距离的判别模型可以高灵敏度和高特异性地将N与恶性肿瘤(BCC和MEL)区分开。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号